Subjects - Business

The inability to pull the trigger on key marketing decisions is a curious problem. On one hand, a properly selected, well-conceived

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

business to business marketing strategy is the key to a company's growth and expansion. For many companies that have been struggling

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

, or are stalled, implementing a marketing solution that will generate leads and sales is Priority One. So, why is it that such a de

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

cision is often put off with some form of “we think we will wait?”

Many business owners and execs have no sense of the tremendous l

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ability of waiting to start a business to business marketing effort. By waiting, they're not confronting how the game is played. Bus

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

iness competition is like a race. When you're not moving forward, you're losing ground.

Although clearly there can be a legitimate

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

reason to delay a business-to-business marketing strategy, there are also reasons that sound reasonable, but which are thinly veiled

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

excuses to put off decision making. Famous examples include: “Even though we're interested, we're not going to start a marketing eff

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ort until things improve first,” “We think marketing will help, but we want to wait until the end of the year,” and “We've got to ge

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

t our ducks in a row so let's talk again in several months.”

There are immediate and long-term benefits that can be achieved throug

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

a full marketing publicity program that illustrate why “waiting” is counter-productive to your strategy.

An aggressive online mark

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

eting publicity program designed to generate Internet news exposure can drive up the client's keyword rankings on Google and Yahoo!.

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

Within weeks of beginning such a program, a properly distributed press release can drive qualified traffic to your website and stim

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ulate call-in leads. Furthermore, dramatic increases in Google rankings can occur in a few months.

60 percent of all Internet sales

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

go to the companies in the top five search results, so every single day that your company is not at the top it is missing out on leg

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

itimate sales opportunities that are being captured by the competition. Generating a large volume of articles published in print is

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

also a critical element in a business to business marketing strategy. but there are inevitable delays in this process. For instance,

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

editors that are approached today with editorial material will likely be working on an issue that won't be out for two to four month

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

s. Waiting to start only compounds the delay and places the company's recovery further into the future.

The sooner you implement an

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

appropriate business to business marketing strategy strategy, the sooner you will benefit from the leads and sales that will result

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/28330/subjects-In-a-Business-to-Business-Marketing-Strategy-the-Big-Wait-is-a-Costly-Mistake.html">In a Business to Business Marketing Strategy, the 'Big Wait' is a Costly Mistake</a>

BB link (for phorums):
[url=http://www.subjects.org.ua/article/28330/subjects-In-a-Business-to-Business-Marketing-Strategy-the-Big-Wait-is-a-Costly-Mistake.html]In a Business to Business Marketing Strategy, the 'Big Wait' is a Costly Mistake[/url]

Do you want to turn your business into an innovation machine where process improvements, problem-solving and bold new product ideas become the norm? Create the business context structure and focus on the long-term leadership commitment and communication activities required to execute them.

When can I reuse a corrugated box for shipping? There are some pitfalls in reusing corrugated boxes to ship products back. Here are the problems to avoid.

Have financial freedom, without even trying. Millionaire reveals the secrets to financial success, with no risk to yourself. Follow a simple program, little or no money needed to start with.

Tags

Links

Subjects - In a Business to Business Marketing Strategy, the 'Big Wait' is a Costly Mistake

Related Articles: